CLINICAL_TRIALS
trial_result
· 2016-07-18
Clinical Trial Update: Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin [Phase 4]
Summary
This Phase 4 trial compared three-times-daily unfractionated heparin to twice-daily enoxaparin for venous thromboembolism prophylaxis after trauma; results were…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Scripps Health | Conditions: Venous Thromboembolic Disease, Deep Vein Thrombosis | Phase 4 | Status: COMPLETED | Results posted: 2016-07-18